Hodgkin Disease - Research News and Information

Saturday, January 10, 2009

Scholastic achievement of children with lymphoma or Wilms tumor at the end of comprehensive education--a nationwide, register-based study.

13 Nov 2008 Cancer treatment may affect school performance. School report grades after childhood lymphomas and Wilms tumor have not been previously reported. All Finnish patients with Wilms tumor (N = 74), Hodgkin lymphoma (HL) (N = 99) and non-Hodgkin ... Read more...

Evidence for a pathophysiological role of cysteinyl leukotrienes in classical Hodgkin lymphoma.

13 Nov 2008 Classical Hodgkin lymphoma (cHL) is characterized histologically by a minority of malignant Hodgkin Reed-Sternberg cells surrounded by abundant inflammatory cells, generally believed to be of major importance in the pathophysiology of the disease. ... Read more...

BCL2 and BCL3 are recurrent translocation partners of the IGH locus.

13 Oct 2008 Chromosomal translocations affecting the immunoglobulin heavy chain (IGH) locus in chromosomal band 14q32 are the most frequent cytogenetic changes in B-cell lymphomas. We studied the presence of IGH translocations in a consecutively ascertained ... Read more...

Learn Faster Today      Improve your study skills

Latest indexed articles for 'Hodgkin Disease'

These are the very latest articles for this heading:

• Scholastic achievement of children with lymphoma or Wilms tumor at the end of comprehensive education--a nationwide, register-based study. 13 Nov 2008
• Evidence for a pathophysiological role of cysteinyl leukotrienes in classical Hodgkin lymphoma. 13 Nov 2008
• Prognostic factors in children with Hodgkin disease. 30 Oct 2008
• BCL2 and BCL3 are recurrent translocation partners of the IGH locus. 13 Oct 2008
• Developing anticancer chemotherapy services in a developing country: Hodgkin lymphoma experience. 29 Sep 2008
• Racial/ethnic variation in EBV-positive classical Hodgkin lymphoma in California populations. 29 Sep 2008
• [Recent advances and the treatment strategies of AIDS-related malignant lymphoma] 29 Sep 2008
• Post-transplant lymphoproliferative disorders after heart or kidney transplantation at a single centre: presentation and response to treatment. 14 Sep 2008
• Cancer risks among relatives of children with Hodgkin and non-Hodgkin lymphoma. 13 Sep 2008
• High-dose therapy and autologous stem cell transplantation for chemoresistant Hodgkin lymphoma: the Seattle experience. 13 Sep 2008
• A mechanism for the HLA-A*01-associated risk for EBV+ Hodgkin lymphoma and infectious mononucleosis. 13 Sep 2008
• Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis. 13 Sep 2008
• Progress in the curative treatment of childhood hematologic malignancies. 7 Sep 2008
• Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004. 7 Sep 2008
• The Epstein-Barr virus oncoprotein, latent membrane protein-1, reprograms germinal centre B cells towards a Hodgkin's Reed-Sternberg-like phenotype. 30 Aug 2008
• Expression of Epstein-Barr virus in Hodgkin lymphoma in a population of United Arab Emirates nationals. 30 Aug 2008
• Primary pulmonary Hodgkin's lymphoma: a rare pitfall in transthoracic fine needle aspiration cytology. 30 Aug 2008
• Adoptive cell therapy against EBV-related malignancies: a survey of clinical results. 30 Aug 2008
• Elevated FDG uptake in Kaposi sarcoma mimicking Hodgkin's lymphoma relapse. 30 Aug 2008
• Understanding the risk of second malignant tumors in children with Hodgkin's disease. 30 Aug 2008

See a longer list of these articles.

Technical information about 'Hodgkin Disease'

Definition: A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.

Descriptor UI: D006689

Alternative terms: Hodgkin Disease; Disease, Hodgkin; Hodgkins Disease; Disease, Hodgkins; Diseases, Hodgkins; Hodgkins Diseases; Hodgkin's Lymphoma; Hodgkin's Lymphomas; Hodgkins Lymphoma; Lymphoma, Hodgkin's; Lymphomas, Hodgkin's; Lymphogranuloma, Malignant; Lymphogranulomas, Malignant; Malignant Lymphogranuloma; Malignant Lymphogranulomas; Hodgkin Lymphoma; Hodgkin Lymphomas; Lymphoma, Hodgkin; Lymphomas, Hodgkin; Hodgkin's Disease; Disease, Hodgkin's; Granuloma, Hodgkin's; Hodgkin's Granuloma; Granuloma, Hodgkin; Hodgkin Granuloma; Granuloma, Malignant; Malignant Granuloma; Malignant Granulomas; Granuloma, Hodgkins; Hodgkins Granuloma;

Related Mesh Headings: Reed-Sternberg Cells;

Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; urine; veterinary; ultrasonography; virology;

Tree Number: C04.557.386.355; C15.604.515.569.355; C20.683.515.761.355;

History Note: 98(66)